Know the Roles of Remdesivir and IL-6 Inhibitors for COVID-19

You'll get questions about remdesivir or interleukin-6 (IL-6) inhibitors for hospitalized COVID-19 patients.

Remdesivir is an investigational IV antiviral with in vitro activity against the SARS-CoV-2 virus that causes COVID-19.

Observational data suggest improvements in oxygenation. And a recent trial in severe COVID-19 patients with pneumonia shows no benefit...but it was stopped early due to low enrollment.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote